29.04.2010 • NewsBASFQ1 2010

BASF: Strong Start to 2010

BASF CEO Jürgen Hambrecht said he expects the economic recovery over the...
BASF CEO Jürgen Hambrecht said he expects the economic recovery over the course of the year to become slower and increasingly uneven.

In the first quarter of 2010, BASF has reported an increase in demand across all regions with Asia remaining as the main driver of growth. The chemical maker saw Q1 sales increase 26% to €15.5 billion over last year. Ebit before special items was up 98% to €1.95 billion. The company said the restocking of inventories among customers has helped to accelerate recovery.

From a regional standpoint, sales in Europe were 12% higher than in the same period 2009. North American sales saw a 55% jump in growth in dollars, 47% in euro.

CEO Jürgen Hambrecht said he has a positive outlook for the further development of 2010, but said that "recovery remains shaky." The company said the risks result mainly from the continuing financial and debt crisis, which is intensifying in some areas, the winding down of national stimulus
programs, volatile raw materials markets, excess capacities, growing geopolitical tensions, and protectionism.

Despite the global economic upturn in the first quarter of 2010, Hambrecht said he expects the economic recovery over the course of the year to become slower and increasingly uneven.

"This is primarily due to the basis effect through the comparison with the previous year," he said.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.